Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Ema uses AI-powered agents to automate tasks in HR, customer support, and data management, making enterprise workflows more efficient.
Clinical stage biotechnology company developing restorative treatments for people affected by neuropsychiatric & neuroimmunologic disorders
Nucleai is a spatial biology company that has developed an AI-powered platform to enhance drug development and improve patient outcomes.
ROME Therapeutics is developing novel therapies for cancer and autoimmune diseases by harnessing the power of the repeatome.
Inceptive designs RNA molecules using large-scale deep learning in a tight loop with high-throughput experiments.
TwinStrand Biosciences develops and commercializes the duplex sequencing technology for DNA sequencing.
AltPep provides a novel approach for tackling amyloid diseases, with diagnostic, therapeutic and anti-biofilm applications.
Delve Bio is a biotechnology company that provides molecular insights for the precision care of patients.
Function Oncology is a precision medicine company advancing a CRISPR-powered personalized functional genomics platform.
Faro Health is a company that handles the tedious work better left for a computer.
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Transforming networks to be more agile, reliable, and secure
Swadesh is a digital bank that allows customers to invest, remit, and manage their money in India from abroad.
BigHat Biosciences is a protein therapeutics company that develops an antibody design platform guided by artificial intelligence.
MOMA Therapeutics operates as a biotechnology company.
Parallel Finance is a Polkadot - based decentralized finance protocol that offers lending and staking services.
Satellite Bio specializes in cell therapy, regenerative medicine, synthetic biology, cell biology, and tissue engineering.
Effortlessly build and deploy AI voice agents. Enterprises trust Syllable AI agents for remarkable performance.
Cue is a healthcare technology company that enables people to manage their health through actionable and connected health data.
Nodexus is democratizing access to live single cells for applications including gene editing, drug development, and more.
Exai Bio is an orphan non-coding RNAs and AI-based liquid biopsy company.
Parthenon Therapeutics is a biotech company inventing a novel class of anti-cancer therapies that reprogram the tumor microenvironment.
Gretel is a multimodal synthetic data platform that leverages advanced generative AI and privacy-enhancing technologies.
ImmuneID is a precision immunology company that provides a technological platform to deliver insights into the human immune response.
S32 has invested in 102 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
S32's top investment sectors include Biotechnology, Health Care, Artificial Intelligence (AI), Software, Therapeutics. The firm invests across 32 different industry categories.
Among tracked funding rounds, GeneDx received $150.0M in a Post Ipo Equity round. S32's total known invested capital is $4.6B.
S32's average investment size is $50.0M across its portfolio of 102 companies.
Recent S32 portfolio additions include Ema, Autobahn Therapeutics, Nucleai, ROME Therapeutics, Inceptive. These companies were founded in 2020 or later.